Drug Discovery

Can HPV Vaccines Protect Those Who Aren't Vaccinated?
Research & Development Can HPV Vaccines Protect Those Who Aren't Vaccinated?

A sweeping nationwide study from Sweden has delivered a definitive answer to one of public health’s most critical questions, demonstrating that high-coverage vaccination programs against the human papillomavirus (HPV) create a powerful shield of protection that extends even to those who have not

Genetic Study Finds Caffeine May Lower Fat and Diabetes Risk
Research & Development Genetic Study Finds Caffeine May Lower Fat and Diabetes Risk

The daily ritual of drinking coffee or tea may hold deeper health implications than previously understood, and the secret appears to lie not in the cup, but within our own DNA. A landmark study leveraging large-scale genetic data has uncovered a compelling causal link between the way an

Pulmocide Halts Fungal Drug Trial Over Mortality Risk
Research & Development Pulmocide Halts Fungal Drug Trial Over Mortality Risk

The development of new medicines for the most critically ill patients is a path fraught with immense challenges, where promising breakthroughs can be abruptly overshadowed by unforeseen safety concerns. In a significant and unexpected development, London-based biopharmaceutical company Pulmocide

Infections Drive Senescence and Accelerate Aging
Research & Development Infections Drive Senescence and Accelerate Aging

The persistent feeling of being physically older and less resilient following a serious illness is no longer just a subjective complaint but is now understood as a tangible biological process driven by cellular damage. Many who recover from infections like influenza or COVID-19 report lingering

Could Natural Compounds Starve Liver Cancer?
Research & Development Could Natural Compounds Starve Liver Cancer?

A comprehensive analysis of recent oncological research has illuminated a remarkably promising therapeutic strategy for hepatocellular carcinoma (HCC), a notoriously aggressive and increasingly prevalent form of liver cancer. This investigation centers on the synergistic application of two natural

Nanoparticles Prime Resistant Tumors for Immunotherapy
Research & Development Nanoparticles Prime Resistant Tumors for Immunotherapy

A significant portion of cancer patients do not respond to immunotherapy because their tumors are immunologically inactive, but a groundbreaking collaborative study from Cornell University researchers has unveiled a remarkable solution using ultrasmall fluorescent silica nanoparticles, known as

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later